Ipilimumab and Imatinib Mesylate in Advanced Cancer
Conditions
- Advanced Malignant Solid Neoplasm
- C-KIT Tyrosine Kinase Protein Overexpression
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Gastrointestinal Stromal Tumor
- Metastatic Malignant Solid Neoplasm
- Metastatic Melanoma
- Pathologic Stage IV Cutaneous Melanoma AJCC v8
- Unresectable Melanoma
- Unresectable Solid Neoplasm
Interventions
- DRUG: Imatinib Mesylate
- BIOLOGICAL: Ipilimumab
Sponsor
M.D. Anderson Cancer Center
Collaborators